Cinti Sandro K, Barnosky Andrew R, Gay Steven E, Goold Susan Dorr, Lozon Marie M, Kim Kristin, Rodgers Phillip E, Baum Nancy M, Cadwallender Bruce A, Collins Curtis D, Wright Carrie M, Winfield Robert A
Infectious Diseases, University of Michigan Hospitals/VA Ann Arbor Health Systems, Ann Arbor, Michigan 48105, USA.
Biosecur Bioterror. 2009 Sep;7(3):311-6. doi: 10.1089/bsp.2009.0019.
We are currently in the midst of the 2009 H1N1 pandemic, and a second wave of flu in the fall and winter could lead to more hospitalizations for pneumonia. Recent pathologic and historic data from the 1918 influenza pandemic confirms that many, if not most, of the deaths in that pandemic were a result of secondary bacterial pneumonias. This means that a second wave of 2009 H1N1 pandemic influenza could result in a widespread shortage of antibiotics, making these medications a scarce resource. Recently, our University of Michigan Health System (UMHS) Scarce Resource Allocation Committee (SRAC) added antibiotics to a list of resources (including ventilators, antivirals, vaccines) that might become scarce during an influenza pandemic. In this article, we summarize the data on bacterial pneumonias during the 1918 influenza pandemic, discuss the possible impact of a pandemic on the University of Michigan Health System, and summarize our committee's guiding principles for allocating antibiotics during a pandemic.
我们目前正处于2009年甲型H1N1流感大流行之中,秋冬季节的第二波流感可能导致更多肺炎患者住院治疗。1918年流感大流行的最新病理学和历史数据证实,那次大流行中许多(即便不是大多数)死亡病例是由继发性细菌性肺炎导致的。这意味着2009年甲型H1N1流感大流行的第二波疫情可能导致抗生素广泛短缺,使这些药物成为稀缺资源。最近,我们密歇根大学医疗系统(UMHS)的稀缺资源分配委员会(SRAC)将抗生素添加到了一份资源清单(包括呼吸机、抗病毒药物、疫苗)中,这些资源在流感大流行期间可能会变得稀缺。在本文中,我们总结了1918年流感大流行期间细菌性肺炎的数据,讨论了大流行对密歇根大学医疗系统可能产生的影响,并总结了我们委员会在大流行期间分配抗生素的指导原则。